Result
€74,417 €74,417
Back in profit in 2025, after a loss of €2,177 in 2024.
SYNAPTICORE
Overview
Lifetime
2 annual accounts with figures on one time axispeak €102,193 (2025)
€102,193▲ €103,982
lowest -€2,177 (2024)
€74,417▲ €76,594
peak €73,241 (2025)
€73,241▲ €74,417
€9,941▲ 298%
Board2 names since 2024
2 directorsBOUCHEZ David Yvan Daniel and 1 other
Documentsfilings and deeds
30-06-202631 days before the deadline
2025micro format
Gross margin from -€1,789 to €102,193Back to profit: €74,417Equity from -€1,177 to €73,241Debts from €2,499 to €9,941Cash from €1,000 to €15,925
Key points
from the 2025 annual accountsInvestments
€23,705 25.4 × depreciation
Green is investment, beige is depreciation.
Position in the sector
88.0%
Higher solvency than 86% of companies in head offices and management consultancy. Sector median 55.5% · 39,368 companies.
Checked score
98
Excellent
Financially stronger than 84% of micro companies in head offices and management consultancy (NACE 70)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.1% across 48,572 companies (NACE 70, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
01-2026: 0.2%
02-2026: 0.2%● unchanged vs 01-2026
03-2026: 0.2%● unchanged vs 02-2026
04-2026: 0.2%● unchanged vs 03-2026
05-2026: 0.2%● unchanged vs 04-2026
06-2026: 0.2%● unchanged vs 05-2026highest value
07-2026: < 0.1%▼ -0.2 percentage points vs 06-2026lowest value
08-2026: 0.1%▲ +0.1 percentage points vs 07-2026
09-2026: 0.1%● unchanged vs 08-2026
10-2026: < 0.1%▼ -0.1 percentage points vs 09-2026
11-2026: 0.1%▲ +0.1 percentage points vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
Founded in 2024
lowers risk
Sector: Activities of head offices; management consultancy activities (NACE 70)
Liquidity: current ratio 6.08, cash €15,925
Equity €73,241 (88.0% of total assets)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 70, micro). It does better than 86% of them on solvency, 65% on liquidity, 84% on profitability and 99% on growth.
The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 11,279 companies had the same profile as SYNAPTICORE has now. Each dot stands for 29 companies, two years later.
96.6%
were still trading
2.6%
stopped another way
0.7%
went bankrupt
That fits the bankruptcy probability of SYNAPTICORE itself: 0.1% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 11,279 companies, not a prediction for SYNAPTICORE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €7,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity is ample, with a current ratio of 6.08, above the usual 1.5. Short-term debt is 12% and cash 19.1% of total assets. 12% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 2 filingsDeviation from the deadline
2025
31 days early
2024
30 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 2 accounts on average 31 days before the deadline. In the sector (NACE 70), the median for financial year 2024 was 9 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsWhere today falls in the filing period
10-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1017271167
Incorporation
Founder: BOUCHEZ David Yvan Daniel (comparant) · 100 shares · Appointments: BOUCHEZ David Yvan Daniel (director) and RIDREMONT Céline (director) · published on 16-12-2024 · Gazette deed
First establishment
Hoeflaan 6, Uccle
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| SYNAPTICORE Uccle | €83,182 | €102,193 | 88.0% | - |
| SAFE AND SECURE SKIES Uccle | €96,561 | €98,610 | 81.4% | - |
| ELKL Consulting Uccle | €80,990 | €86,665 | 67.9% | - |
| Artisot Uccle | €96,642 | €93,960 | 76.9% | - |
| ADL Advisory Uccle | €92,853 | €95,824 | 82.7% | - |
| ProNemiga Woluwe-Saint-Lambert | €86,649 | €86,182 | 82.7% | - |
| Belani Ganshoren | €86,088 | €115,952 | 91.6% | - |
These companies have the same main activity as SYNAPTICORE: business and other management consultancy (NACE 70200). They are comparable in size and age: total assets between €81,000 and €96,600, founded between 2024 and 2025.
Official details
Source: KBO- Status
- Active since 12-12-2024Normal situation
- Activity
- Business and other management consultancyNACE 70200and 4 others
- Establishment unit
- 2.367.660.7261180 Uccle, since 12-12-2024
- Financial year end
- 31 December
- Peppol
- Reachable since 30-12-2025
Annual accounts 2025
- €102,193
- ≈ €170,000estimated
- €74,417
- €73,241
- €83,182▲ 63×
- Filing
- Filed on 30-06-2026, 31 days before the end of the filing period
Insights on SYNAPTICORE
SYNAPTICORE has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €73,241 and a net result of €74,417.
Its solvency ranks better than 87% of 39,368 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Financials
Annual accounts 2025
micro format, filed on 30-06-2026, 31 days before the deadline€102,193
▲ €103,982
€100,830
▲ €103,006
€74,417
▲ €76,594
€50,469
▲ €51,646
88.0%
6.08
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €170,000. Estimated: probably between €150,000 and €210,000.
Balance sheet
balance sheet total €83,182 on 31-12-2025What the company ownsHow it is paid for
in euro
in euro
Position in the sector
88.0%
Higher than 87% of 39,368 companies in 2025.
6.08
Higher than 82% of 38,051 companies in 2025.
89.5%
Higher than 95% of 38,523 companies in 2025.
SYNAPTICORE
Middle half of the sector
80% of the sector
Micro accounts in head offices and management consultancy (NACE 70)
Net result: top quarter · Equity: middle half · Balance sheet total: middle half · Working capital: middle half
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 |
|---|---|---|---|
| Balance sheet: assets | |||
20/58 |
83,182 | 1,322 | |
21/28 |
22,771 | - | |
22/27 |
22,771 | - | |
26 |
22,771 | - | |
29/58 |
60,410 | 1,322 | |
40/41 |
33,003 | 322 | |
40 |
16,394 | - | |
41 |
16,609 | 322 | |
54/58 |
15,925 | 1,000 | |
490/1 |
11,482 | - | |
| Balance sheet: equity and liabilities | |||
10/49 |
83,182 | 1,322 | |
10/15 |
73,241 | -1,177 | |
10/11 |
1,000 | 1,000 | |
14 |
72,241 | -2,177 | |
17/49 |
9,941 | 2,499 | |
42/48 |
9,941 | 2,499 | |
44 |
3,103 | 246 | |
440/4 |
3,103 | 246 | |
45 |
6,838 | - | |
450/3 |
6,838 | - | |
47/48 |
- | 2,253 | |
| Income statement | |||
9900 |
102,193 | -1,789 | |
630 |
934 | - | |
640/8 |
430 | 387 | |
9901 |
100,830 | -2,177 | |
75/76B |
384 | - | |
75 |
384 | - | |
65/66B |
211 | - | |
65 |
211 | - | |
9903 |
101,003 | -2,177 | |
67/77 |
26,585 | - | |
9904 |
74,417 | -2,177 | |
9905 |
74,417 | -2,177 | |
| Appropriation of the result | |||
9906 |
72,241 | -2,177 | |
14P |
-2,177 | - | |
| Document | |||
The notes to these accounts have 6 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 30-06-2026.
Filings
each dot is a set of accounts, on the day it reached the National BankKey figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 |
|---|---|---|---|
| 101,763 | - | ||
| 75,351 | - | ||
| 23,705 | - | ||
| 14,925 | - | ||
| 50,469 | -1,177 | ||
| 88.0% | - | ||
| 6.08 | - | ||
| 0.14 | - | ||
| 101.6% | - | ||
| 89.5% | - | ||
| over 100 | - |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Investments
fixed assets acquired| Item | 2025 | 2024 |
|---|---|---|
| Tangible fixed assets | €23,705 | - |
| €934 | - |
Source: notes to the 2024 to 2025 annual accounts (statement of fixed assets)
Insights on SYNAPTICORE
The operating result for 2025 is a profit of €100,830, after a loss of €2,177 in 2024.
Debt's share of the balance-sheet total is 12.0%.
Board & ownership
Board
2 directors, since incorporationDirector (not named in the articles)
appointed by deed of 16-12-2024
term without a fixed end
listed in the 2025 annual accounts, filed on 30-06-2026
Director (not named in the articles)
appointed by deed of 16-12-2024
term without a fixed end
listed in the 2025 annual accounts, filed on 30-06-2026
Mandates through the years
2 names, the dashed line is todayBOUCHEZ David Yvan Daniel
Director (not named in the articles)
Director (not named in the articles)
RIDREMONT Céline
Director (not named in the articles)
Director (not named in the articles)
Board
Mandates as a list
- BOUCHEZ David Yvan Daniel
- Director (not named in the articles), from 11-12-2024 to date
- RIDREMONT Céline
- Director (not named in the articles), from 11-12-2024 to date
Control
Capital
- Contribution
- €1,000
- Shares
- 100
- Contribution per share
- €10
- Equity per share
- €732 in 2025
- Source
- 2025 annual accounts
Articles of association
deed of 16-12-2024 (in French)- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Moitié cédant moitié acquéreurs proportionnellement nombre actions si plusieurs, nullité”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Last Friday of June at 18:00
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one.
- No statutory auditor
Shareholders
At incorporation
deed of 16-12-2024 ↗
- BOUCHEZ David Yvan Daniel 100 shares (100%) · in cash
Network & group
No group
SYNAPTICORE has no parent and no holdings in its annual accounts.
At the same address
Hoeflaan 6, 1180 Uccle · 1 other company| Dr C. Ridremont, pédiatre
registered office since 13-12-2024 · founded in 2024 |
total assets €176,156 (2025) 1017.385.785 |
Earlier ties
| FREE AIR via BOUCHEZ David Yvan Daniel, no longer at FREE AIR · Manager · deed of 14-09-2018 No longer active |
total assets €7,054 (2020) |
Connections & network
The network starts from the earlier ties.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Timeline
Timeline
7 events since 2024Filings
Financial
Establishments
202420252026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBmicro format · 31 days before the deadline
2025
Back to profit net €74,417 The net result is €74,417, after one loss-making year.
Liquidity more than 11 times current ratio 6.08 The current ratio rises from 0.53 to 6.08.
Registered in the Peppol Directory Reachable for e-invoices through 0208:1017271167
Annual accounts 2024 filed NBBmicro format · 30 days before the deadline
2024
IncorporationFounder: BOUCHEZ David Yvan Daniel (comparant) · 100 shares · Appointments: BOUCHEZ David Yvan Daniel (director) and RIDREMONT Céline (director) · published on 16-12-20245 points ▸
- Founder, BOUCHEZ David Yvan Daniel (comparant)
- 100 shares, mentioned twice in the deed
- Registered office clause, avenue du Hoef 6, 1180 Uccle
- Director appointment, BOUCHEZ David Yvan Daniel (director (not named in the articles))
- Director appointment, RIDREMONT Céline (director (not named in the articles))
- The deed holds 3 more points.
First establishment Hoeflaan 6, Uccle
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Identity
- Enterprise number
- 1017.271.167
- VAT number
- BE 1017.271.167
- Peppol ID
- 0208:1017271167
- Legal form
- Private limited company
- Status
- Active, normal situation
- Founded
- 12-12-2024
- Financial year
- ends on 31 December
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Last Friday of June at 18:00deed of 16-12-2024 (in French)
- Peppol
- Reachable since 30-12-2025Follow this company and you will hear the next morning if it leaves the Peppol register.
- Name
- SYNAPTICORE in French
- Entity type
- Legal entity
- Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
- “Région de Bruxelles-Capitale”deed of 16-12-2024 (in French)
Activities
NACEBEL 202570200
Business and other management consultancy main activity
85599
Other education
Codes under NACEBEL 2008
70220
Business consulting main activity
72190
Scientific research and development
73200
Advertising, market research and public relations activities
82990
Other business support services
85599
Other education
- PurposeThe purpose describes the activities the company may carry out under its articles.
- “La fourniture de tous services,études et conseils liés directement ou indirectement à la recherche clinique,les affaires scientifiques et…”deed of 16-12-2024 (in French)
14 activities
- La fourniture de tous services,études et conseils liés directement ou indirectement à la recherche clinique,les affaires scientifiques et médicales et au développement de produits issus des sciences de la santé pour l’industrie des soins de santé,les institutions de santé et de soins,et les prestataires de services auprès de ceux-ci. Ces activités comprennent notamment le conseil et l’implémentation de stratégie de recherche clinique,la mise en place de structure de recherche clinique,d’assurance qualité et de contrôle de qualité,et leurs procédures,la gestion de projets,la préparation et soumission de dossiers réglementaires ou de remboursement,le support terrain,technique et scientifique,l’analyse et l’interprétation de données,le stockage,la gestion et le traitement de données (y compris électroniquement et par intelligence artificielle),la préparation de présentations et d’articles scientifiques,la formation à la recherche clinique,
- Toutes activités se rapportant directement ou indirectement à la consultance,le management et l’organisation d’entreprise,le coaching,la formation,la fourniture de services et la réalisation d’études dans les domaines sus-décrits,
- La valorisation de toutes connaissances techniques ;
- La prestation de tous services de développement commercial,administratifs,informatiques ou de gestion au sens le plus large ;
- L’acquisition,la détention,la gestion et l’exploitation de brevets ainsi que de tous droits intellectuels,
- Les services de traduction,d’interprète et autres activités d’administration.
- À la location de biens immobiliers lui appartenant en propre,
- À l’activité de marchand de biens immobiliers,cette activité recouvrant l’achat,la vente,la rénovation ou la construction d’immeubles d’habitation,commerciaux ou industriels destinés à la revente,
- À la réalisation de toutes opérations relatives à la promotion immobilière,à l’activité d’administrateur de biens,et la prise et la remise de fonds de commerce.
- Consentir tous prêts,crédits et avances sous quelque forme que ce soit et pour quelque durée que ce soit,à toutes entreprises affiliées ou dans laquelle la société possède une participation ;
- Se voir octroyer,sous quelque forme que ce soit et pour quelque durée que ce soit,tous prêts,crédits et avances par toute personne physique ou morale dans le cadre de ses activités. ;
- Donner caution,aval ou toutes garanties généralement quelconques,tant pour ses propres engagements que pour les engagements de tiers,entre autres en donnant ses biens en hypothèque ou en gage,y compris son fonds de commerce ;
- L’acquisition et la gestion de participations sous n’importe quelle forme dans toutes sociétés belges et étrangères,tant en vue de les valoriser qu’en exercice pur et simple de mandats d’administration ;
- L’exercice de toutes activités patrimoniales.
Registered office and establishments
1 establishment| Establishment | Since | Unit number |
|---|---|---|
| Hoeflaan 6 registered office 1180 Uccle | 12-12-2024 | 2.367.660.726 |
Buildings and parcels at the address
- Ground area
- 148 m²
- Buildings
- 84 m²
- Volume, LiDAR
- 705 m³
- Tallest building
- 11.7 m
Buildings to scale, each on its own parcel
Parcels
| Cadastral parcel | Area | Buildings | Height / floors |
|---|---|---|---|
| 21612C0210/00H008 | 148 m² | 1 · 84 m² | 11.7 m · 3 |